. 2021 Dec 7;8:746515. doi: 10.3389/fnut.2021.746515

Table 3.

Body weight, Body fat, and Fermentation variables at the end of Phase 2.

	OP means (SE)				OR means (SE)				P-value After ANOVA
	VA	NA	LX	WA	VA	NA	LX	WA
Energy intake Kcal/d)	83.4 (4.01)	76.2 (3.08)	74.6 (1.62)	78.1 (3.62)	77.6 (1.89)	74.1 (2.87)	78.0 (1.92)	77.0 (1.18)	ns
Body weight (g)	477.3 (11.3)^a	470.4 (13.9)^a	454.5 (16.3)^a	460.8 (19.5)^a	371.7 (13.4)^b	360.1 (11.0)^b	359.8 (6.01)^b	361.9 (5.72)^b	<0.001
EBW (g)	464.8 (27.6)^a	456.9 (33.6)^a	445.8 (50.0)^a	448.8 (47.1)^a	370.1 (31.7)^b	351.2 (25.6)^b	359.8 (15.5)^b	359.9 (16.6)^b	<0.001
Abdominal fat (g)	26.4 (1.77)^a	26.2 (2.13)^a	25.1 (3.54)^a	26.3 (3.94)^a	11.2 (1.90)^b	8.35 (1.17)^c	10.6 (1.61)^b	9.84 (3.94)^b	<0.001
Full Cecum weight (g)	12.3 (0.67)^a	12.2 (1.48)^a	11.76 (1.35)^a	12.64 (1.51)^a	3.36 (0.19)^b	3.62 (0.28)^b	3.19 (0.25)^b	3.80 (0.64)^b	<0.001
Empty Cecum weight (g)	1.36 (0.07)^a	1.28 (0.1)^a	1.43 (0.12)^a	1.51 (0.20)^a	0.75 (0.03)^b	0.87 (0.07)^b	0.83 (0.06)^b	0.85 (0.07)^b	<0.001
Total SCFAs (nmole/cecum)	0.59 (0.06)^a	0.87 (0.04)^a	0.65 (0.04)^a	0.61 (0.03)^a	0.10 (0.01)^b	0.15 (0.01)^b	0.12 (0.01)^b	0.14 (0.02)^b	<0.001
pH of cecal contents	5.64 (0.8)^a	5.78 (0.1)^a	5.65 (0.2)^a	5.89 (0.23)^a	6.9 (0.12)^b	7.2 (0.24)^b	6.8 (0.56)^b	6.9 (0.21)^b	0.005
Total Bacteria per g cecal samples (X 10⁸ gene copies of 16S gene)	1.4 (0.03)^a	1.1 (0.02)^a	1.6 (0.04)^b	1.0 (0.03)^a	0.73 (0.03)^c	0.72 (0.006)^c	1.09 (0.03)^a	0.66 (0.01)^c	<0.01

VA, Vancomycin; NA, Neomycin and Ampicillin; LX, MiraLAX® WA, Water; EBW, Embowelled body weight. P-value is for overall test (ANOVA), Different letters indicate significant differences after Tukey's test of multiple comparisons.